Biznesradar bez reklam? Sprawdź BR Plus
Wiadomości INC
1.180+0.010(+0.85%)INC S.A.
GPW - Akcje - Notowania ciągłe
Biznesradar bez reklam? Sprawdź BR Plus
Ultra Clean Holdings, Inc. plunged 8.3% on Monday to $42.49 as a broad selloff hammered semiconductor equipment stocks across the board. The Hayward, Califo...
The post Ultra Clean Holdings Drops 8.3% Amid Sector-Wide Selling first appeared on Alphastreet.
Penguin Solutions, Inc. tumbled 7.1% on Monday as a sector-wide selloff dragged down shares of the information technology services provider and its peers. T...
The post Penguin Solutions Drops 7.1% Amid Sector-Wide Selling first appeared on Alphastreet.
Jaguar Health, Inc. (JAGX) posted Q3 2026 basic and diluted EPS of -$9.23.
The post Jaguar Health Releases Q3 2026 Financial Results first appeared on Alphastreet.
Larimar Therapeutics, Inc.
The post Larimar Therapeutics Releases Q3 2026 Financial Results first appeared on Alphastreet.
ALX Oncology Holdings Inc.
The post ALX Oncology Holdings Releases Q3 2026 Financial Results first appeared on Alphastreet.
Phunware, Inc. (PHUN) posted Q3 2026 basic and diluted EPS of -$0.34.
The post Phunware Releases Q3 2026 Financial Results first appeared on Alphastreet.
Creative Realities, Inc.
The post Creative Realities Releases Q3 2026 Financial Results first appeared on Alphastreet.
VIDA Global Inc. (VIDA) posted Q3 2026 basic and diluted EPS of -$0.11.
The post VIDA Global Releases Q3 2026 Financial Results first appeared on Alphastreet.
Galectin Therapeutics Inc.
The post Galectin Therapeutics Releases Q3 2026 Financial Results first appeared on Alphastreet.
LanzaTech Global, Inc.
The post LanzaTech Global Releases Q3 2026 Financial Results first appeared on Alphastreet.
Pearl Diver Credit Company Inc.
The post Pearl Diver Credit Company Releases Q3 2026 Financial Results first appeared on Alphastreet.
Lexeo Therapeutics, Inc.
The post Lexeo Therapeutics Releases Q3 2026 Financial Results first appeared on Alphastreet.
22nd Century Group, Inc.
The post 22nd Century Group Releases Q3 2026 Financial Results first appeared on Alphastreet.
Unicycive Therapeutics, Inc.
The post Unicycive Therapeutics Releases Q3 2026 Financial Results first appeared on Alphastreet.
Cocrystal Pharma, Inc. (COCP) posted Q3 2026 basic and diluted EPS of -$0.20.
The post Cocrystal Pharma Releases Q3 2026 Financial Results first appeared on Alphastreet.
Natural Alternatives International, Inc. (NAII) posted Q1 2027 diluted EPS of -$0.41.
The post Natural Alternatives International (NAII) Reports Q1 2027 Numbers first appeared on Alphastreet.
Gemini Space Station, Inc. (GEMI) reported Q3 2026 basic and diluted loss of $0.46 per share, a narrower loss than the -$0.54 estimate (14.8% narrower).
The post Gemini Space Station Releases Q3 2026 Financial Results first appeared on Alphastreet.
BIO-key International, Inc.
The post BIO-key International Releases Q3 2026 Financial Results first appeared on Alphastreet.
Aardvark Therapeutics, Inc.
The post Aardvark Therapeutics Releases Q3 2026 Financial Results first appeared on Alphastreet.
SPAR Group, Inc.
The post SPAR Group Releases Q3 2026 Financial Results first appeared on Alphastreet.
Biznesradar bez reklam? Sprawdź BR Plus
Biznesradar bez reklam? Sprawdź BR Plus
Informacje
| ISIN: | PLINCLT00015 |
|---|---|
| Data debiutu: | 09.08.2006 |
| Liczba akcji: | 15 043 099 |
| Kapitalizacja: | 17 750 857 |
| Enterprise Value: | 16 271 857 |
| Branża: | Działalność inwestycyjna |
INC funkcjonuje w obszarze inwestycji oraz doradztwa na rynku kapitałowym. Spółka specjalizuje się w pomocy i wsparciu małym i średnim spółkom... INC funkcjonuje w obszarze inwestycji oraz doradztwa na rynku kapitałowym. Spółka specjalizuje się w pomocy i wsparciu małym i średnim spółkom działającym w różnych sektorach. Poza prywatnymi przedsiębiorstwami, INC świadczy również usługi doradcze jednostkom samorządu terytorialnego oraz angażuje się w projekty sportowe, kulturalne i akademickie.
| Nazwa: | INC S.A. |
|---|---|
| Adres: | ul. Abpa Antoniego Baraniaka 6, 61-131, Poznań, Polska |
| CEO: | Paweł Śliwiński |
| NIP: | 7781024498 |
| REGON: | 630316445 |
| KRS: | 0000028098 |
| WWW: | http://www.incsa.pl/ |
Biznesradar bez reklam? Sprawdź BR Plus

